Immunaccel Labs Stock

Drug development efficiency platform

About Immunaccel Labs Stock

N/A

Other Companies

D2iQ (fka Mesosphere)

Cloud native platform and application management

$271MTotal Funding

Learn More

DoorDash

Local restaurant delivery platform

$2.1BTotal Funding

Learn More

OfferUp

Mobile marketplace to buy and sell locally

$263MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Immunaccel Labs or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.